PREVENTION OF LEFT VENTRICLE SYSTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AFTER CARDIAC REVASCULARIZATION

Article English OPEN
A. L. Alyavi; B. A. Alyavi; M. L. Kenzhaev; S. R. Kenzhaev;
(2016)
  • Publisher: Stolichnaya Izdatelskaya Kompaniya
  • Journal: Racionalʹnaâ Farmakoterapiâ v Kardiologii (issn: 1819-6446, eissn: 2225-3653)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.20996/1819-6446-2009-5-4-33-38, doi: 10.1234/1819-6446-2009-4-33-38
  • Subject: corvitin | RC666-701 | RM1-950 | систолическая дисфункция | Therapeutics. Pharmacology | обратимая дисфункция миокарда | Diseases of the circulatory (Cardiovascular) system | systolic dysfunction | корвитин | reversible systolic dysfunction | реперфузионное повреждение | reperfusion complication

<p><strong>Aim.</strong> To study effects of bioflavonoid quercetin (corvitin) on left ventricle (LV) systolic dysfunction in patients with acute coronary syndrome with ST segment elevation (ACS+ST) after cardiac revascularization.</p><p><strong>Material and methods.</s... View more
Share - Bookmark